Cardiac Conduction System Disease: Clinical Trials

97 trials for Cardiac Conduction System Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

59 completed, 22 unknown, 6 terminated, 4 recruiting. 97 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 497Completed 59, Unknown 22, Terminated 6, Recruiting 4, Active not recruiting 2, Not yet recruiting 2, Withdrawn 2

Follow Cardiac Conduction System Disease: new trials by email Literature Review of Cardiac Conduction System Disease trials Research Report on Cardiac Conduction System Disease

Trials (filtered) newest first · largest first

All 97 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adenosine vs Diltiazem for Treatment of SVT in the ED
adenosine, diltiazem - Supraventricular Tachycardia (SVT)
Phase 4RecruitingAnne E. Zepeski202025-08-012026-05-28
EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)
Methylprednisolone (Corticosteroid), Placebo - Transcatheter Aortic Valve Replacemen, Left Bundle Branch Block
Phase 4Not yet recruitingXiao-dong Zhuang2002025-01-012025-01-07
Diltiazem in Jervell and Lange-Nielsen Syndrome
diltiazem - Jervell and Lange Nielsen Syndrome
Phase 4CompletedVanderbilt University Medical Center12024-10-162025-10-14
Adenosine vs. Diltiazem
Adenosine intravenous, Diltiazem intravenous - Supraventricular Tachycardia (SVT), Atrioventricular Nodal Re Entrant Tachycardia
Phase 4CompletedHaseki Training and Research Hospital1402024-07-012026-03-06
Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT
Single-syringe Adenosine, Double Syringe Adenosine - Supraventricular Tachycardia, Supraventricular Tachycardias
Phase 4CompletedHormozgan University of Medical Sciences1342024-05-212026-11-06
Micra AV Tracking During Exercise Testing
Medtronic Micra AV Device - Heart Block AV
Phase 4WithdrawnDuke University2024-05-012024-04-17
Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation
Ampicillin sulbactam 3 days, Placebo 3 days - Heart Block, CIED Related Infection
Phase 4CompletedUniversitas Diponegoro602024-04-012025-02-27
Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS
Experimental group, Control group - Premature Ventricular Contractions, Ventricular Dysfunction, Left
Phase 4Not yet recruitingAssistance Publique - Hôpitaux de Paris2982023-10-012023-09-06
Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).
Methylprednisolone, Placebo - Heart Block, Aortic Stenosis
Phase 4UnknownHospital General Universitario de Alicante1002023-08-122023-10-11
The Leadless AV Versus DDD Pacing Study
Conventional pacemaker DDD, Leadless pacemaker Micra AV - Cardiac Pacemaker, Arrhythmias, Cardiac
Phase 4Active not recruitingInsel Gruppe AG, University Hospital Bern1002022-08-232026-04-29
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced
Phase 4CompletedIndiana University732021-09-022026-10-20
Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial
Catheter Ablation - Premature Ventricular Contraction
Phase 4UnknownRuijin Hospital2002020-10-012020-08-19
Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance
Group 1, CMR-guided/aided VT ablation, Group 2, CMR-aided VT ablation, Group 3, Electroanatomical guided ablation - Ventricular Tachycardia, Myocardial Fibrosis
Phase 4CompletedAzienda Ospedaliero, Universitaria Pisana1042020-08-032025-12-15
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
Progesterone, Ibutilide - Long QT Syndrome, Abnormalities, Drug-Induced
Phase 4CompletedIndiana University272019-03-262025-07-01
Targeted Potassium Levels for Prevention of ICD Therapy
Targeted serum potassium level - Ventricular Arrhythmias and Cardiac Arrest, Implantable Defibrillator User
Phase 4Active not recruitingCopenhagen University Hospital, Rigshospitalet12002019-03-012025-05-09
Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
Nifekalant hydrochloride, Amiodarone - Ventricular Tachycardia, Ventricular Fibrillation
Phase 4UnknownSichuan Baili Pharmaceutical Co., Ltd.7562019-01-152019-02-27
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)
Radiofrequency ablation, Amiodarone (Antiarrhythmic drug) - Ventricular Premature Beats, Contractions, or Systoles, Cardiomyopathies
Phase 4UnknownHunter Holmes Mcguire Veteran Affairs Medical Center52018-08-012021-04-14
Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients
Dexamethasone, Normal saline - Coronary Artery Disease, Inflammatory Response
Phase 4CompletedUniversitas Indonesia1202018-07-012022-08-04
MANual vs. automatIC Local Activation Time Annotation for Guiding Premature Ventricular Complex Ablation
Automatic annotation of LAT (WF-method), Manual annotation of LAT (M-method) - Ventricular Premature Complexes, Catheter Ablation
Phase 4CompletedCentro Medico Teknon1002018-06-262020-10-20
MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
Beta-blocker treatment group - Idiopathic Ventricular Fibrillation, Cardiac Arrest, Out-Of-Hospital
Phase 4RecruitingBo Gregers Winkel2182018-05-012026-09-01

Showing 20 of 97. Sign in to see all of them.

Narrower conditions

Tachycardia, Ventricular (32)  ·  Tachycardia (17)  ·  Arrhythmias, Cardiac (13)  ·  Ventricular Premature Complexes (12)  ·  Sick Sinus Syndrome (11)  ·  Atrial Fibrillation (10)  ·  Ventricular Fibrillation (10)  ·  Heart Failure (9)  ·  Bradycardia (8)  ·  Atrioventricular Block (7)  ·  Tachycardia, Supraventricular (7)  ·  Bundle-Branch Block (5)  ·  Heart Block (5)  ·  Long QT Syndrome (5)  ·  Tachycardia, Atrioventricular Nodal Reentry (5)

Broader conditions

Pathologic Processes (97)  ·  Pathological Conditions, Signs and Symptoms (97)  ·  Heart Diseases (95)  ·  Cardiovascular Diseases (94)  ·  Arrhythmias, Cardiac (84)  ·  Tachycardia (40)  ·  Heart Block (19)  ·  Cardiac Complexes, Premature (14)  ·  Arrhythmia, Sinus (10)  ·  Vascular Diseases (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Cardiovascular Abnormalities (5)  ·  Congenital Abnormalities (5)  ·  Heart Defects, Congenital (5)

Interventions

Catheter Ablation (8)  ·  Amiodarone (7)  ·  Defibrillators, Implantable (5)  ·  Sotalol (4)  ·  Adenosine (3)  ·  Flecainide (3)  ·  Procainamide (3)  ·  Progesterone (3)  ·  Remifentanil (3)  ·  ibutilide (3)  ·  Albuterol (2)  ·  Anti-Arrhythmia Agents (2)  ·  Diltiazem (2)  ·  Ivabradine (2)  ·  Methylprednisolone (2)

Sponsors

Biotronik SE & Co. KG (6)  ·  Medtronic Cardiac Rhythm and Heart Failure (6)  ·  Boston Scientific Corporation (4)  ·  Medtronic BRC (4)  ·  Indiana University (3)  ·  LivaNova (3)  ·  Biosense Webster, Inc. (2)  ·  Deutsches Herzzentrum Muenchen (2)  ·  Hospital Clinic of Barcelona (2)  ·  John Sapp (2)  ·  Vanderbilt University Medical Center (2)  ·  Aarhus University Hospital Skejby (1)  ·  Anne E. Zepeski (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda Ospedaliero, Universitaria Pisana (1)

Countries

United States (31)  ·  Germany (18)  ·  Italy (10)  ·  Canada (7)  ·  China (7)  ·  Denmark (7)  ·  Spain (7)  ·  Austria (6)  ·  France (6)  ·  United Kingdom (6)  ·  Belgium (5)  ·  Czechia (5)  ·  Israel (4)  ·  Switzerland (4)  ·  Finland (3)

Top investigators

James E Tisdale, PharmD (3)  ·  Gerhard Hindricks, Prof. Dr. (2)  ·  William G Stevenson, MD (2)  ·  Adem Az (1)  ·  Alonso Pedrote, MD, PhD (1)  ·  Andrea Natale, MD (1)  ·  Angel Arenal, Dr. (1)  ·  Anne Zepeski, PharmD (1)  ·  Anthony L Tang, MD FRCPC (1)  ·  Anthony S Tang, MSc, MD, FRCPC (1)  ·  Antonio Berruezo, MD, PhD (1)  ·  Antonio Curnis, Dr. (1)  ·  Arcadio Garcia-Alberola, Dr. (1)

Results publications

PMID 16403928, PMID 16818810, PMID 16836672, PMID 18996055, PMID 19261367, PMID 19901194, PMID 20569728, PMID 21098435, PMID 21156772, PMID 21960699, PMID 21978966, PMID 22016074, PMID 22773022, PMID 23050527, PMID 23322010, PMID 23419655, PMID 23868932, PMID 24509688, PMID 25131977, PMID 25282033, PMID 25762533, PMID 26314489, PMID 26559916, PMID 26868693, PMID 27149033, PMID 28292751, PMID 28685712, PMID 29025197, PMID 29239759, PMID 29251799, PMID 29305400, PMID 29581554, PMID 29957265, PMID 30949218, PMID 31389718, PMID 31614244, PMID 31698933, PMID 32216911, PMID 32395337, PMID 32413467, PMID 33020898, PMID 34362264, PMID 34392257, PMID 34711192, PMID 35210082, PMID 35421939, PMID 37467227, PMID 38649085, PMID 39445764, PMID 39555820

NIH funding

2005 (1), 2009 (1), 2017 (1), 2018 (1), R01HL153114 (1), R34HL138110 (1), UL1RR024975-01 (1), UL1TR000445-06 (1)